Systaaq Diagnostic Products

Executive Summary

Systaaq Diagnostic Products is a US-based molecular diagnostics company specializing in real-time PCR kits, reagents, and nucleic acid extraction products for infectious disease testing. Founded in 2012 and headquartered in San Diego, the company operates under GMP and ISO 13485 certifications and offers both CE-marked IVD and research-use-only products. Despite a limited public profile, Systaaq is well-positioned to capitalize on the growing demand for rapid, accurate diagnostic solutions, particularly in the post-pandemic landscape. The company's established manufacturing capabilities and regulatory compliance provide a foundation for potential expansion into new markets or product lines. However, as a private entity with no disclosed funding or revenue, near-term visibility remains low, and competitive pressures from larger diagnostics firms pose challenges. Nonetheless, Systaaq's niche focus and operational footprint in the US and EU markets suggest potential for selective growth through product innovation and strategic partnerships.

Upcoming Catalysts (preview)

• Q4 2026New product launch (e.g., multiplex respiratory panel)60% success
• H2 2026Regulatory approval (FDA 510(k) or CE-IVDR certification)50% success
• Q3 2026Strategic partnership or distribution agreement70% success